A meaningful portion of my practice involves reconstructive work, not the kind that follows trauma or cancer, but the kind that follows cosmetic procedures that went wrong. Patients come to me after abdominoplasties that developed into sepsis, after injections administered by unlicensed individuals, after hair transplants that left permanent scarring. Much of what I do in the consultation room is assess what can be improved, what cannot be reversed, and what a patient’s realistic options are from here. This is the part of cosmetic surgery that the public rarely sees. And it is the part that has shaped everything I believe about what patients need to understand before they make a surgical decision.
After years in practice, certain patients leave a permanent mark on you. They are not always the most technically difficult cases. More often, they are the patients sitting across from you with injuries that should never have progressed as far as they did, explaining how a procedure that was presented as affordable, straightforward, and life-changing turned into a medical crisis. What makes these consultations linger is not the complexity of the revision work ahead, but the weight of what trust costs when it is misplaced. These patients came to someone who said they could help. They handed over their bodies, their money, and their hope, and what they received in return caused harm that will follow them for the rest of their lives. That exchange, and what it means for the physician who sees them afterward, is what I want to address here.
I want to be clear about something at the outset: Excellent surgical care is available outside the United States, and I am not suggesting otherwise. The question I am raising is not about where surgery is performed. It is about what happens after. What system is in place if something goes wrong? Who is accountable? Who can the patient call at two in the morning when something does not feel right? The answer to those questions matters as much as the surgeon’s credentials or the facility’s price, and it is the question that gets asked far less often than it should.
Two distinct categories of risk
Before describing the cases I want to share, I think it is worth drawing a clear distinction between two categories of risk that sometimes get conflated in conversations about cosmetic surgery complications. The first is medical tourism: procedures performed by credentialed surgeons at established facilities abroad, pursued primarily because of cost. The second is a fundamentally different problem: procedures performed by unlicensed individuals operating outside any regulated medical environment, sometimes in private homes or informal settings. These are not the same issue. They share some overlapping consequences, but the underlying risks, the accountability structures, and the appropriate policy responses are quite different. I will describe cases from both categories, and I want readers to understand them as distinct.
Three cases
The first patient underwent a combination abdominoplasty and breast augmentation at a facility in Mexico. She had researched the provider carefully and chose it because the cost was approximately one-third of what she had been quoted domestically. She was discharged within 24 hours and flew home. Within days of returning, she developed signs of infection that progressed rapidly to sepsis, requiring ICU admission, emergency reoperation, and an extended hospitalization. Her acute care team managed the crisis effectively, but the tissue damage from the infection had permanently widened her abdominal scar in the areas where the skin had been most compromised. She came to me months later. The infection was likely preventable. The scarring was not reversible. This is the part patients never see when the procedure is being sold to them.
The second case involves a categorically different situation. A patient presented with chronic pain, significant soft tissue irregularity, and hardened deposits throughout her buttocks and thighs following silicone injections administered in her home by an unlicensed woman who offered house calls. Industrial-grade liquid silicone migrates through tissue, incites chronic inflammation, and becomes encapsulated in fibrous scar tissue that is painful and extraordinarily difficult to address surgically. We performed staged excision of the most symptomatic areas and achieved meaningful improvement, but complete removal was not possible without causing damage that would exceed the original problem. She will live with permanent scar tissue and chronic discomfort. The individual who performed the injections faced no professional consequences because she held no professional credentials to lose. This is not a medical tourism story. It is a story about the absence of any medical framework at all.
The third patient underwent follicular unit extraction at a high-volume facility in Istanbul and presented more than a year later with extensive scarring across the donor and recipient areas of his scalp, visible tethering of the surrounding skin, and permanent reduction in sensation. Scar revision in previously operated scalp tissue is technically demanding because the vascular supply is less predictable and the tissue has limited elasticity. We improved the scarring and released the tethering, but the sensory deficits were permanent. What complicated his recovery was not simply what had happened in Istanbul. It was that by the time he sought help, the opportunity for earlier intervention had passed, and the records from his procedure were incomplete and difficult to interpret.
The central issue: continuity of care
The common thread in these cases is not geography, and I want to be careful not to suggest that it is. Complications can occur anywhere, including in accredited facilities in the United States, and even the most skilled surgeons work within a margin of risk that no credential eliminates. What I have learned from the patients who come to me after difficult outcomes is that access to the surgeon who operated on you, and a system that holds someone accountable when things go wrong, is one of the most important factors in how a complication resolves. When something changes in the days or weeks after surgery, the ability to reach the operating surgeon directly, to be seen promptly, and to have a treatment team that knows what was done and can act on that knowledge is often what determines how the story ends.
Distance complicates this in ways that are worth taking seriously. A patient recovering from surgery in another country, or flying home shortly after a procedure, may face meaningful delays in accessing appropriate care if something develops. Surgery activates the body’s clotting system as part of normal healing, and prolonged immobility can compound that response. Deep vein thrombosis and pulmonary embolism are recognized risks in the postoperative period, and a patient experiencing warning signs (chest pain, shortness of breath, rapid heartbeat) far from her surgical team and her medical records is in a more vulnerable position than one who is recovering nearby. These are not reasons to avoid surgery abroad categorically. They are reasons to plan for them explicitly, and to ask hard questions before making a decision.
The volume of surgery performed in a single session matters as well. Combining procedures is common and, when carefully planned, entirely appropriate. What I regularly see are patients who were cleared for aggressive combinations of procedures at other practices, often to reduce anesthesia costs, without adequate consideration of what that recovery actually demands. More surgery in less time means a more complex and prolonged recovery, which makes the absence of nearby, accessible follow-up care that much more consequential. The patient absorbs all of it, alone.
The question is not whether surgery can be performed
ADVERTISEMENT
Procedures are completed every day at facilities around the world, and many patients return home without incident. What I have learned from the patients who do not is that resources mean something different than most people assume when they are researching a procedure abroad: access to the surgeon who operated on you, and a system that holds someone accountable when things go wrong.
What patients should ask before traveling for surgery
For patients who are considering surgery abroad, I would encourage a different kind of due diligence than most people currently undertake. Before traveling, patients should confirm the surgeon’s credentials and whether they are recognized by an accrediting body equivalent to the American Board of Medical Specialties. They should verify that the facility is accredited by an independent organization with transparent standards. They should ask specifically what the follow-up care protocol is, not whether follow-up exists, but what it looks like in practice, and how the team handles complications that develop after discharge. They should ask what the plan is if something goes wrong and they are already home: Who do they call, what records will be available to a domestic treating physician, and in what format. They should understand the recommended interval between surgery and travel, based on the specific procedures being performed, and they should have a plan in place for accessing appropriate local medical care if they need it before they are home.
These are not questions designed to discourage patients from pursuing care abroad. They are questions that any patient should be asking of any surgeon, in any country. The fact that they are asked less often in the context of medical tourism is part of what creates the vulnerability I see in my practice.
What physicians across specialties should know
The patients I have described are increasingly likely to present to emergency medicine physicians, internists, and specialists across disciplines who may not immediately connect the clinical picture to a recent cosmetic procedure. The CDC published data earlier this year documenting 145 patients with serious complications from travel-related cosmetic procedures, including 4 deaths, numbers that represent confirmed, reported cases and almost certainly undercount the actual volume. Eliciting a complete history that includes recent cosmetic procedures, regardless of where they were performed or by whom, is becoming an increasingly relevant part of the clinical encounter. Operative reports may be unavailable or written in a language the treating team cannot read. Materials used may be unknown or misrepresented. Patients are often reluctant to disclose the circumstances of their procedure, and that reluctance delays care.
Most complications from poorly performed cosmetic surgery can be improved. Very few can be fully reversed. The patients I have described were not careless. They were people who wanted something for themselves and made the best decision they could with the information they had. What they lacked was an honest account of what the downside looked like (who would be responsible, who would be reachable, and what the path forward would be if something went wrong). Helping patients ask those questions before they make a decision is something physicians across specialties are well positioned to do.
David Feldmar is a plastic and reconstructive surgeon.
